Patient | ARV drug regimens | Mutations selected in the PR | Mutations selected in the RT | Corresponding line in table 2 |
---|---|---|---|---|
A | d4T-3TC-NFV | V62A, V71I, L99F | M184V | 14 |
d4T-ABC-LPV/r | + S43I, K45R, V47A, I89V | + I10V, K35T, K82R, Y115F, Q151M | 3 | |
B | AZT-3TC-ABC | M184V | 20 | |
d4T-3TC-ABC-TDF | + A62V, K65R, V111I | 17 | ||
C | AZT-3TC-NVP | Q151M, M184V | 23 | |
ddI-TDF-ABC | + K65R, N69T, V111I, D218E | 18 | ||
3TC-ABC-TDF | + I90V, S215T | 21 | ||
D | d4T-3TC-NFV | T56A, V62M, V71I | M184V | 11 |
E | d4T-3TC-NFV | V71I/T (*) | 5 | |
F | 3TC-ABC-FPV/r | I54M, I89V, L90M | M184V | 27 |
G | AZT-3TC-ABC | K65R, N69S, V83I, I90V, V111I, M184I/V, F214L, Q151M, Y115F | 16 | |
H | AZT-3TC-ABC | M184V | 22 | |
TDF-FTC-ATV/r | L90M | 6 | ||
I | AZT-3TC-ABC | M184V, K70N, K35R, K64R, K82R, Q151M | 19 |